Square 1 Provides Credit Facility to Heat Biologics
Square 1 Bank announced that it provided a credit facility to RTP-based Heat Biologics, a clinical-stage immunotherapy company. Proceeds of the credit facility will be used to support ongoing clinical trials and company growth.
The Chapel Hill, NC-based Heat Biologics focuses on developing its ImPACT (Immune Pan-Antigen Cytotoxic Therapy) therapeutic vaccines to combat a wide range of cancers and infectious diseases.
“Square 1 Bank has been an excellent partner for Heat Biologics by providing valuable, strategic advice related to finance. The team at Square 1 listened to our needs and provided creative solutions that met the strategic goals of our company,” said Jeff Wolf, founder and chief executive officer.
Square 1 Bank is a full-service commercial bank that serves the financial needs of the venture capital community and entrepreneurs in all stages of growth and expansion.